HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Palatal Polymorphous Adenocarcinoma with High-Grade Transformation: A Case Report and Literature Review.

Abstract
Polymorphous adenocarcinoma (PAC) is the second most common intraoral malignant neoplasm of the minor salivary glands. However, it is very rare for PAC to show high-grade transformation (HGT) and to our knowledge, the English literature only seven reported cases. HGT tends to be observed when PAC recurs, and it is extremely rare to be seen at initial presentation. Here we report a 43-year-old Japanese male patient with PAC of the right palate showing HGT at initial presentation. Histopathologically, the tumor was characterized by a prominent solid and papillary-cystic growth pattern, with nuclear atypia and necrosis in area of HGT. The immunohistochemical staining pattern was consistent with PAC, as the tumor cells showed diffuse positivity for cytokeratin, vimentin and S-100, and focal positivity for bcl-2, ɑ-SMA and EMA. The tumor cells in HGT areas were markedly positive for AR and Ki-67 (about 40%/HPF), and also focally positive for cyclin D1 and p53, whereas HER2/neu, ER, PgR, p63, D2-40, GCDFP-15, and mitochondria were negative. Here we present a very rare case of palatal PAC with HGT at initial presentation.
AuthorsKentaro Kikuchi, Toshitaka Nagao, Fumio Ide, Shota Takizawa, Hideaki Sakashita, Ichiro Tsujino, Tie-Jun Li, Kaoru Kusama
JournalHead and neck pathology (Head Neck Pathol) Vol. 13 Issue 2 Pg. 131-139 (Jun 2019) ISSN: 1936-0568 [Electronic] United States
PMID29594833 (Publication Type: Case Reports, Journal Article)
Topics
  • Adenocarcinoma (pathology)
  • Adult
  • Cell Transformation, Neoplastic (pathology)
  • Humans
  • Male
  • Palate, Hard (pathology)
  • Salivary Gland Neoplasms (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: